RxDoctor Payments Data

Derek Johnson, MD

Adult Reconstructive Orthopaedic Surgery · Parker, CONPI 1295946283

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.7%), speaking fees and royalties or licence payments — rather than concentrated in one kind of arrangement. Conformis, Inc. accounts for 60.7% of it on its own, with 24 other manufacturers making up the rest. Among adult reconstructive orthopaedic surgery clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$181,279in general payments, 2019–2025

Across 234 payments — averaging $774.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Conformis, Inc.$110K
  • Restor3d, Inc.$67K
  • Medacta USA, Inc.$1K
  • Stryker$949
  • Zimmer Biomet$770
  • UOC USA Inc$260
  • plus $1K from 19 others
$351,049in research payments, 2019–2025

Across 132 payments — averaging $2659.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$293K
  • Conformis, Inc.$46K
  • Omnilife Science, Inc$5K
  • Corin USA$4K
  • Medacta USA, Inc.$3K

What the payments were for

  • Royalty or licence$27,00115%
  • Consulting fees$93,74252%
  • Speaking & faculty fees$40,82623%
  • Travel & lodging$12,1397%
  • Food & beverage$7,5714%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$181,279 in reported general payments places this provider in the 90th percentile of 31 adult reconstructive orthopaedic surgery providers in Colorado.

See all adult reconstructive orthopaedic surgery providers in Colorado

Medicare billing

Part B allowed, 2024
$379,164
Medicare patients
589
Services billed
8,426

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam345$2,304
Celecoxib14$546
Amoxicillin42$109
Tramadol Hcl13$70

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Parker

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →